Calnex Solutions PLC Exercise of Options (8778O)

TIDMCLX

RNS Number : 8778O

Calnex Solutions PLC

15 June 2022

15 June 2022

Calnex Solutions plc

("Calnex" or the "Company")

Exercise of Options

Calnex Solutions plc (AIM: CLX), an established provider of test and measurement solutions for the global telecommunications sector, announces that the Company has today issued a total of 23,935 new ordinary shares of 0.125 pence each ("New Shares"), pursuant to the exercise of options issued under the Company's EMI Share Option Plan.

Application will be made for the admission of the New Shares to trading on AIM ("Admission"). The New Shares will rank pari passu with the existing Ordinary Shares and it is expected that Admission will become effective on or around 8.00 a.m. on 20 June 2022.

Following Admission, the Company's issued share capital will consist of 87,523,935 Ordinary Shares with voting rights. Calnex does not hold any Ordinary Shares in treasury. This figure of 87,523,935 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they require to notify their interest in, or a change to their interest in, the share capital of the Company under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For more information, please contact:

 
 Calnex Solutions plc                   Via Alma PR 
 Tommy Cook, Chief Executive Officer 
  Ashleigh Greenan, Chief Financial 
  Officer 
 
                                        [phone] 
 Cenkos Securities plc - NOMAD           6939 
 Derrick Lee, Peter Lynch 
 
                                        + 44(0) 20 3405 
 Alma PR                                 0213 
 Caroline Forde, Hannah Campbell, 
  Joe Pederzolli 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOEEAKKLFADAEFA

(END) Dow Jones Newswires

June 15, 2022 02:00 ET (06:00 GMT)